Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 8, Number 8—August 2002

Pandrug-Resistant Acinetobacter baumannii Causing Nosocomial Infections in a University Hospital, Taiwan

Po-Ren Hsueh*, Lee-Jene Teng*, Cheng-Yi Chen*, Wen-Hwei Chen*, Shen-Wu Ho*Comments to Author , and Kwen-Tay Luh*
Author affiliations: *National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan;

Main Article

Table 2

Results of time-kill study of two isolates of pandrug-resistant Acinetobacter baumannii (PDRAB)

MIC (µg/mL)a
Isolate I
Isolate II
Antibiotic (clone 5) (clone 6)
Imipenem 32 32
Amikacin 128 64
Ciprofloxacin 128 2
Ampicillin-sulbactam 128 32
Imipenem + amikacin 16/64 2/4
Imipenem + ciprofloxacin 32/128 4/0.25
Imipenem + ampicillin-sulbactam 16/64 8/8
Ciprofloxacin + ampicillin-sulbactam 128/128 1/16

aValues are the lowest concentrations (µg/mL) of each agent in combination that yielded synergy.

Main Article

Page created: July 16, 2010
Page updated: July 16, 2010
Page reviewed: July 16, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.